Preterm Infant Formula: Marketing and Safety Rules
A house committee must act next: committee consideration.
Most bills like this struggle to pass unless they get a lot of support from both parties or become part of a much larger health package.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Parents and families of preterm infants would gain stronger protections against misleading advertising for preterm infant formula, since the FTC would be required to investigate and then ban deceptive marketing that hides health risks or fails to explain differences between human milk-based and bovine-based fortifiers. The bill also states that formula makers should not be allowed to limit families' ability to pursue legal action if their infant is harmed, though this specific provision is a non-binding sense of Congress rather than an enforceable rule.
“no manufacturer of preterm infant formula or related products should be permitted to limit, evade, or otherwise diminish the ability of families to pursue legal recourse when their preterm infants experience harm.”
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Baby Brent’s Bill
Analysis generated by AI. Always verify with official sources.